emka TECHNOLOGIES is a biotechnology startup founded in 1991, specializing in scientific instruments for preclinical research. The company has achieved a prominent position in the pharmacology, safety pharmacology, and toxicology research community by providing a diverse range of software and hardware solutions, complemented by various services. Its customer base spans across different research fields, including cardiovascular, pulmonary, and neurology. emka TECHNOLOGIES' offerings cater to activities such as isolated organs, electrophysiology, telemetry, PV loops, and behavior studies.
The company distinguishes itself by not only providing products but also offering essential services such as installation, validation, maintenance, training, and support to its global customer network. Through a network of offices, emka TECHNOLOGIES efficiently serves regional and national markets while also establishing partnerships with leading research instrument manufacturers. This strategic approach allows the company to create a strong ecosystem to deliver its solutions effectively.
As of now, specific details on the startup's headquarters, last investment, or the involved investors are not available. Despite this, emka TECHNOLOGIES' extensive history and dedicated focus on providing comprehensive solutions in the biotechnology sector position the company as a significant player in the preclinical research industry, with ample potential for further growth and impact.
There is no investment information
No recent news or press coverage available for emka TECHNOLOGIES.